Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RAPP

Rapport Therapeutics Inc

May 29 • 04:00PM ET

39.50

+0.01 0.03 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ACAD DNLI XENE KYMR NUVL AXSM INCY KRYS BIIB NBIX

| Held by: VTI IWM VXF IWN IBB XPH SCHA VTWO DFAS IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.60	Insider Own	40.57%	Shs Outstand	47.81M	Perf Week	7.63%
Market Cap	1.89B	Forward P/E	-	EPS next Y	-4.33	Insider Trans	-4.85%	Shs Float	28.44M	Perf Month	19.70%
Enterprise Value	1.42B	PEG	-	EPS next Q	-0.90	Inst Own	76.04%	Short Float	8.50%	Perf Quarter	36.07%
Income	-107.28M	P/S	94.46	EPS this Y	-17.64%	Inst Trans	3.04%	Short Ratio	7.06	Perf Half Y	38.21%
Sales	20.00M	P/B	4.00	EPS next Y	-28.69%	ROA	-26.83%	Short Interest	2.42M	Perf YTD	30.19%
Book/sh	9.86	P/C	3.96	EPS next 5Y	-19.76%	ROE	-28.33%	52W High	42.27 -6.55%	Perf Year	364.16%
Cash/sh	9.97	P/FCF	-	EPS past 3/5Y	-114.24% -	ROIC	-22.36%	52W Low	7.73 411.00%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	95.00%	Volatility	4.39% 6.20%	Perf 5Y	-
Dividend TTM	-	EV/Sales	71.15	EPS Y/Y TTM	-18.14%	Oper. Margin	-611.03%	ATR (14)	2.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	27.08	Sales Y/Y TTM	-	Profit Margin	-536.38%	RSI (14)	61.49	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	27.08	EPS Q/Q	38.38%	SMA20	5.80%	Beta	0.97	Target Price	57.10
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	13.43%	Rel Volume	1.01	Prev Close	39.49
Employees	84	LT Debt/Eq	0.02	Earnings	May 07 BMO	SMA200	39.07%	Avg Volume	342.33K	Price	39.50
IPO	Jun 07, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	30.64% 166.67%	Trades		Volume	344,914	Change	0.03%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)